EMEA-001142-PIP01-11-M03

Key facts

Invented name
Zerbaxa
Active substance
  • Ceftolozane
  • tazobactam
Therapeutic area
Infectious diseases
Decision number
P/0154/2019
PIP number
EMEA-001142-PIP01-11-M03
Pharmaceutical form(s)
Powder for concentrate for infusion
Condition(s) / indication(s)
  • Treatment of intra-abdominal infections
  • Treatment of urinary tract infections
Route(s) of administration
Intravenous use
Contact for public enquiries
Merck Sharp & Dohme (Europe), Inc.

E-mail: pip.information@merck.com
Tel. +33 (0)180464738

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating
Average
1 rating